3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
32
Colonic Neoplasms
8
Rectal Neoplasms
7
Neoplasm Metastasis
5
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Gallbladder Neoplasms
3
Cholangiocarcinoma
3
Neutropenia
2
Bile Duct Neoplasms
2
Adenocarcinoma
2
mCRC
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Microsatellite-stable Colorectal Cancer
1
Lung Neoplasms
1
High-grade Extra Pulmonary Neuroendocrine Cancer
1
Gastric Cancer Adenocarcinoma Metastatic
1
First-line Treatment
1
Esophageal Squamous Cell Carcinoma
1
EFS
1
Dihydropyrimidine Dehydrogenase Deficiency
1
Clinical Stage III Gastric Cancer AJCC v8
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Oxaliplatin
26
Gemcitabine
22
Fluorouracil
17
Capecitabine
16
Leucovorin
15
pembrolizumab
14
Docetaxel
14
Cisplatin
13
Bevacizumab
12
Radiotherapy
8
Paclitaxel
8
Irinotecan
8
Trastuzumab
7
Pemetrexed
6
Carboplatin
6
130-nm albumin-bound paclitaxel
6
durvalumab
5
cemiplimab
5
Erlotinib Hydrochloride
5
Sunitinib
4
Ramucirumab
4
Metformin
4
Gefitinib
4
trastuzumab deruxtecan
3
tislelizumab
3
cabozantinib
3
atezolizumab
3
Taxes
3
Sorafenib
3
Panitumumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Adenocarcinoma
×
trifluridine tipiracil drug combination
×
Clear all
NCT05476796
2024-10-24
LOGICAN
UNICANCER
Phase 2
Recruiting
118 enrolled
NCT02921737
2021-02-04
UF-STO-PANC-003
University of Florida
Phase 2
Terminated
7 enrolled
12 charts